The WHITE Study [WHIch decision after a first venous ThromboEmbolism?] is an international, no profit, multicenter, prospective, observational study, that involves nine Countries (China, Czech Republic, Mexico, Portugal, Poland, Romania, Russia, Slovakia, and Tunisia). The study aimed to evaluate the distribution of decisions and of the reasons guiding the physician’s decisions on the modality to manage the secondary prevention of VTE in patients treated for a first-ever episode of VTE, after the initial 3-12 months of anticoagulation therapy. The secondary objective is the collection of data on thromboembolic or bleeding complications, or death from any cause monitored during the follow-up.

The results of the WHITE study are published open acess:

• Palareti G, Bignamini AA, Urbanek T, Cini M, Li YJ, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study. Thromb Res. 2022
• Palareti G, Bignamini A, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study. Intern Emerg Med. 2022
• Palareti G, Bignamini AA, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V. Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data from the International, Observational WHITE Study. Clin Appl Thromb Hemost. 2021